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Abstract
Resting T cells undergo a rapid metabolic shift to glycolysis upon activation in the presence of interleukin (IL)-2, in
contrast to oxidative mitochondrial respiration with IL-15. Paralleling these different metabolic states are striking
differences in susceptibility to restimulation-induced cell death (RICD); glycolytic effector T cells are highly sensitive to
RICD, whereas non-glycolytic T cells are resistant. It is unclear whether the metabolic state of a T cell is linked to its
susceptibility to RICD. Our ﬁndings reveal that IL-2-driven glycolysis promotes caspase-3 activity and increases
sensitivity to RICD. Neither caspase-7, caspase-8, nor caspase-9 activity is affected by these metabolic differences.
Inhibition of glycolysis with 2-deoxyglucose reduces caspase-3 activity as well as sensitivity to RICD. By contrast, IL-15-
driven oxidative phosphorylation actively inhibits caspase-3 activity through its glutathionylation. We further observe
active caspase-3 in the lipid rafts of glycolytic but not non-glycolytic T cells, suggesting a proximity-induced model of
self-activation. Finally, we observe that effector T cells during inﬂuenza infection manifest higher levels of active
caspase-3 than naive T cells. Collectively, our ﬁndings demonstrate that glycolysis drives caspase-3 activity and
susceptibility to cell death in effector T cells independently of upstream caspases. Linking metabolism, caspase-3
activity, and cell death provides an intrinsic mechanism for T cells to limit the duration of effector function.
Introduction
The balance of cell proliferation and cell death is critical
for the maintenance of stable cell numbers and tissue
homeostasis. Thus, it is perhaps not surprising that these
opposing processes may be mechanistically linked in
various cell types, including cancer1,2. During an immune
response, T lymphocytes undergo a period of very rapid
proliferation. During this expansion, T cells also become
susceptible to T-cell receptor (TCR) restimulation-
induced cell death (RICD)3,4. However, the link between
proliferation and susceptibility to death remains poorly
understood5.
Changes in cellular metabolism are well recognized to
play a critical role during an effective immune response.
Resting naive T lymphocytes, upon activation, undergo a
dramatic metabolic shift from oxidative phosphorylation
to aerobic glycolysis6–8. The switch to a largely glycolytic
state allows the cell to generate the synthetic capacity
needed for rapid proliferation and effector function, such
as cytokine production. In a similar manner, B cells and
dendritic cells also utilize glycolysis upon activation to
enable their effector functions9,10. Recent studies have
further indicated that the metabolic state of effector
T cells helps determine their subset differentiation11.
Differing metabolic states are also known to be involved
in the speciﬁcation of T-cell memory, with central
memory T cells exhibiting high oxidative phosphorylation
and effector memory T cells being more glycolytic12–14.
It is well appreciated that cell death and metabolism are
closely linked. Glycolytic enzymes can be induced by the
same transcription factors that upregulate the expression
of anti-apoptotic proteins such as BCL-xL15. Other pro-
teins with metabolic function, such as cytochrome c, are
directly involved in cell death15,16. When released from
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the mitochondria, cytochrome c activates caspase-9,
which then cleaves caspase-3 and induces apoptosis.
Caspase-3 can be alternatively activated through cleavage
by caspase-8, which is activated by death receptors such as
Fas (CD95). However, little is known regarding possible
links between metabolism and caspase activity.
Although caspases were originally deﬁned for their role
in cell death, it is now appreciated that caspases perform
many functions in cells in addition to cell death17,18. This
is particularly well established for caspase-8, an initiator
caspase that can induce apoptosis upon ligation of a death
receptor19, but can also allow cell proliferation by inhi-
biting formation of the necroptosome and induction of
necroptosis20. Active caspase-3, a critical downstream
mediator of apoptosis, has also been observed in non-
dying cells and is implicated in skeletal muscle differ-
entiation21, T-cell anergy22, B-cell cycling10, and ery-
throcyte maturation17. However, these studies did not
examine how caspase-3 activity is being regulated in these
non-apoptotic situations. Moreover, an explanation has
been lacking for the molecular switch between TCR-
stimulated proliferation of naive T cells vs. induction of
cell death in effector T cells3,4.
Given the involvement of caspases in both cell death
and non-death functions, regulation of caspase activity
and its location in cells are of paramount importance in
determining cell fate. We have observed that T cells
grown in interleukin (IL)−2 vs. IL-15 have similar
amounts of total pro-caspase-3, but IL-2-cultured
T cells have a substantially higher level of active cas-
pase-3, and as a result are much more susceptible to
RICD23. IL-15-cultured T cells are resistant to this form
of cell death, in part due to the high levels of reactive
oxygen and nitrogen species that lead to the redox
modiﬁcation of a critical cysteine in the active site of
caspase-3, resulting in its inactivation23–25. IL-2 and IL-
15 also induce very different metabolic states in T cells;
IL-2 promotes glycolysis, whereas IL-15 upregulates
oxidative phosphorylation12. We now observe that
caspase-3 activity in non-dying effector T cells is largely
a function of their glycolytic state. Inhibition of glyco-
lysis by a variety of methods reduces caspase-3 activity
and protects T cells from RICD. In addition, IL-15-
cultured T cells further reduce caspase-3 activity
through its inactivation by glutathionylation. These
ﬁndings underscore the importance of cellular meta-
bolism in the regulation of caspase-3 activity and sus-
ceptibility toward cell death.
Results
IL-15 induces mitochondrial ROS and glutathionylation of
caspase-3
To investigate the inﬂuence of cell metabolism on cas-
pase activity, we initially modeled two metabolic states
in vitro using cytokines that are known to promote very
different levels of glycolysis following T-cell activation: IL-
2, which upregulates glycolysis, and IL-15, known to
induce a non-glycolytic state of mitochondrial respira-
tion12. To mimic an immune response in vitro, puriﬁed
naive T cells were activated with anti-CD3/CD28 in the
presence of IL-2 for 2 days, and then removed from sti-
mulation and propagated in IL-2 for an additional day.
The activated T cells were then washed thoroughly to
remove exogenous cytokines and recultured in medium
containing either IL-2 or IL-15 for an additional 3 days. In
agreement with previous observations12, IL-15-cultured
T cells manifested high mitochondrial respiration, as
reﬂected by a high oxygen consumption rate (OCR;
Fig. 1a). Consistent with these ﬁndings, complex I activity
of the electron transport chain was higher in IL-15-
cultured T cells than in IL-2-cultured T cells (Figs. 1b, c).
Complex I is known to generate reactive oxygen species
(ROS)26, and we determined that IL-15 induced a greater
amount of mitochondrial ROS compared to IL-2 (Fig. 1d)
as measured using the mitochondria-targeted probe
mitoboronic acid (MitoB)27. MitoB is converted to mito-
phenol (MitoP) upon reaction with mitochondrial
hydrogen peroxide, and the levels of MitoB and MitoP are
then measured by liquid chromatography tandem mass
spectrometry and expressed as a ratio of MitoP to
MitoB27.
ROS can promote protein glutathionylation, a process
that results in the reversible modiﬁcation of a cysteine
by glutathione28. Caspase-3 has been shown previously
to be inactivated in HL-60 cells by the glutathionylation
of the critical cysteine in the enzymatic pocket25. We
therefore investigated the possibility that caspase-3 is
glutathionylated in IL-15-cultured T cells. Glutathio-
nylated proteins were immunoprecipitated and immu-
noblotted for caspase-3 (Fig. 2a). Caspase-3 was
glutathionylated to a considerably greater extent in the
IL-15-cultured T cells compared to IL-2 (Fig. 2b). Of
interest, the glutathionylation was observed speciﬁcally
on cleaved caspase-3 (Fig. 2a). This implies that full-
length pro-caspase-3 was initially cleaved and then
inactivated by glutathionylation.
Given that IL-15 induced a greater amount of mito-
chondrial ROS compared to IL-2 (Fig. 1d), we examined
the effect of quenching mitochondrial ROS on overall
caspase activity in activated T cells. IL-2- and IL-15-
cultured T cells were incubated with the mitochondria-
targeted antioxidant mitoquinone (MitoQ) to quench
mitochondrial ROS29. MitoQ treatment of IL-15-cultured
T cells, but not IL-2-cultured T cells, induced a reduction
in ROS (Fig. 2c). The lack of effect of MitoQ in IL-2-
cultured T cells may reﬂect a non-mitochondrial source
of ROS, such as cytoplasmic NADPH oxidases. Consistent
with these ﬁndings, MitoQ did not alter caspase activity in
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IL-2-cultured T cells, but did slightly increase caspase
activity in IL-15-cultured T cells, although not to the level
of caspase activity in IL-2-cultured T cells (Fig. 2d).
Consistent with these ﬁndings, treatment with MitoQ did
not affect the sensitivity of IL-2- or IL-15-cultured T cells
to death, either before or after restimulation (Fig. 2e).
Thus, mitochondrially derived ROS partially contributed
to the low level of caspase activity in IL-15-cultured
T cells, but were not solely responsible for the decreased
sensitivity to RICD. We therefore considered that the
pronounced metabolic shift to glycolysis during T-cell
activation might also inﬂuence the activity of certain
caspases and sensitivity to RICD.
Glycolysis drives caspase-3 activation
Glycolysis was measured by extracellular acidiﬁcation
rate (ECAR) in naive T cells, effector T cells (day 6 after
activation), and late effector T cells (day 10 after activa-
tion). Glycolysis increased initially from naive to day 6
T cells, and then decreased from day 6 to day 10 (Fig. 3a).
These changes were greater in the IL-2-cultured T cells
than IL-15. IL-2 signaling is known to drive glycolysis12,
and the kinetics of glycolysis in T cells grown in IL-2
closely paralleled the levels of surface IL-2 receptor α
(CD25) expression, which also peaked and declined over a
nearly identical timespan (Fig. 3b). These results are
consistent with previously reported kinetics of CD25
Fig. 1 IL-15 drives increased oxygen consumption, complex I activity, and mitochondrial ROS. Anti-CD3/CD28-activated T cells were cultured
for 3 days in IL-2 or IL-15. a Oxygen consumption rate (OCR) was measured by extracellular ﬂux analysis. O Oligomycin A (inhibitor of ATP synthase), F
FCCP (uncoupler of the electron transport chain), R/A Rotenone and Antimycin (inhibitors of complexes I and III, respectively; mean ± S.D. of four
replicates within the one experiment shown. The graph is representative of two independent experiments). b Complex I activity was measured in
mitochondrial (Mito) and cytosolic (Cyto) fractions of IL-2- or IL-15-cultured T cells (the graph is representative of two independent experiments). c
Complex I rates of activity in (b) for mitochondrial fractions, normalized to the rate of activity of complex I in mouse liver mitochondria (unpaired t-
test; *p < 0.05; mean ± S.D. of data from two independent experiments). d Mitochondrial ROS were measured by the conversion of mitoboronic acid
(MitoB) to mitophenol (MitoP), and the ratio of MitoP/MitoB was measured by liquid chromatography tandem mass spectrometry (paired t-test; *p <
0.05; mean ± S.E.M. of means from three independent experiments)
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expression30. Concomitant with the rise of glycolysis and
surface CD25 expression following T-cell activation, we
observed an increase in total caspase activity. T cells
propagated in IL-2 continued to increase caspase activity
until a peak on day 6, after which it declined through day
10, closely paralleling ECAR and CD25 expression
(Fig. 3c). As a result of the culturing system and the
introduction of IL-15 on day 3, the ﬁrst measurements of
caspase activity and CD25 expression occurred on day 4
for IL-15-cultured T cells. In the presence of IL-15, CD25
expression and caspase activity remained at a consistently
low level throughout the same 10-day period (Fig. 3c).
The largest difference in caspase activity between IL-2-
and IL-15-cultured T cells was on day 6. We also mea-
sured the level of active caspase-3 by ﬂow cytometry, and
found it to be greater in IL-2-cultured T cells compared
with IL-15-cultured T cells on day 6 (Fig. 3d). Whereas
caspase-3 activity was detected in live IL-2-cultured
T cells, activity was much higher in cells in which death
was induced through Fas stimulation (Fig. 3d). Thus, the
intermediate levels of active caspase-3 in proliferating
T cells were not due to contaminating dead cells, but
rather were present in all IL-2-cultured T cells.
To extend the observed correlation of glycolysis with
caspase activity, we examined CD4+ T-cell functional
subsets, which have been shown to have varying levels of
glycolytic activity11. In vitro-differentiated T helper (Th)1
and Th2 cells were reported to have high levels of gly-
colysis, being slightly higher in Th2 cells. By contrast, in
vitro-differentiated T regulatory (Treg) cells had low
levels of glycolysis. Puriﬁed naive CD4+ T cells were
differentiated into Th1, Th2, and Treg cells in vitro and
their caspase activity was measured. Caspase activity was
highest in the Th2 subset and lowest in the Treg subset,
matching glycolytic activity (Figs. 3e and f).
These collective ﬁndings suggested that glycolysis and
caspase activity might be causally linked. We thus
examined more directly the effect of glycolysis on caspase
Fig. 2 IL-15 induces glutathionylation of caspase-3. Anti-CD3/CD28-activated T cells were cultured in IL-2 or IL-15 for 3 days before lysis. a
Glutathione immunoprecipitation (GSH IP) was performed on whole-cell lysates (WCL). Immunoprecipitations were conducted alongside a reduced
control (+DTT) and an IgG control (IgG). The WCL and GSH IP were immunoblotted for caspase-3 (the immunoblot is representative of three
independent experiments). b Densitometry of cleaved caspase-3 detected in the IL-2 and IL-15 GSH IP lanes in (a), indicative of glutathionylated
cleaved caspase-3 (paired t-test; *p < 0.01; mean ± S.D.; n = 3 independent experiments). c ROS were measured by ﬂow cytometry using DCFDA in IL-
2- or IL-15-cultured T cells in the presence or absence of 200 nM mitoquinone (MitoQ) for 4 h (two-way ANOVA with Sidak’s correction; data indicate
a fold change compared to IL-2 DMSO control; NS not signiﬁcant; *p < 0.05; mean ± S.E.M.; n = 3 independent experiments). d Caspase activity was
measured by DEVD rhodamine ﬂuorescence in IL-2- or IL-15-cultured T cells with or without MitoQ (two-way ANOVA with Sidak’s correction; NS not
signiﬁcant; *p < 0.05; mean ± S.D. of three replicates within the one experiment shown. The graph is representative of two independent experiments).
e IL-2- or IL-15-cultured T cells were incubated with MitoQ (200 nM) or DMSO for 24 h. Restimulation-induced cell death was then promoted by 16 h
anti-CD3 restimulation followed by Live/Dead staining and ﬂow cytometry (two-way ANOVA with Tukey’s correction; NS not signiﬁcant; mean ± S.D.
of two replicates)
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activity. To inhibit glycolysis, IL-2-cultured T cells were
incubated with 2-deoxy-D-glucose (2-DG), a glucose
analog that blocks glucose catabolism after phosphoryla-
tion by hexokinase31. As an inhibitor of glycolysis, 2-DG
could potentially induce cell death in highly glycolytic IL-
2-cultured T cells. To reduce contamination by dead cells,
the 2-DG cell cultures were centrifuged over Histopaque.
The inhibition of glycolysis by 2-DG was conﬁrmed by
measuring a decrease in ECAR (Fig. 4a). In parallel, cas-
pase activity was also decreased, in a dose-dependent
manner, in IL-2-cultured T cells cultured with 2-DG
(Fig. 4b). To conﬁrm that the decrease in caspase activity
was due to the inhibition of glycolysis and not an off-
target effect of 2-DG, we also inhibited glycolysis by two
other methods, culturing IL-2-cultured T cells with
rapamycin or in a low-glucose medium. These treatments
also reduced caspase activity in IL-2-cultured T cells
(Fig. 4b) but not in IL-15-cultured T cells (Fig. 4c).
To determine whether the regulation of caspase activity
by glycolysis was selective for certain caspases, we
examined the levels of speciﬁc caspase activity in IL-2-
cultured T cells in the presence or absence of 2-DG, using
biotin-VAD (bVAD) to selectively precipitate only active
caspases with streptavidin-coated Sepharose beads.
Immunoblot analysis of the precipitates revealed that 2-DG
caused a profound decrease in caspase-3 activity, but had no
effect on the activities of the related effector caspase-7, nor
the upstream caspase-8 or caspase-9 (Figs. 5a, b).
Fig. 3 Caspase activity parallels glycolysis and CD25 expression in T cells. a–c T cells were activated with anti-CD3/CD28 for 2 days and cultured
in IL-2 for a third day. T cells were then washed and cultured in IL-2 or IL-15 for an additional 7 days. a Baseline extracellular acidiﬁcation rate (ECAR)
was measured by extracellular ﬂux analysis on days 0, 6, and 10 (two-way ANOVA with Tukey’s correction; NS not signiﬁcant; *p < 0.01; mean ± S.E.M.
of means from three independent experiments). b CD25 expression measured daily by ﬂow cytometry (the graph is representative of two
independent experiments). c Caspase activity was measured daily by DEVD rhodamine release (mean ± S.D. of three replicates within the one
experiment shown. The graph is representative of two independent experiments). d Anti-CD3/CD28-activated T cells were cultured in IL-2 or IL-15 for
3 days. For a positive control, IL-2-cultured T cells were incubated with FasL for 1.5 h to induce caspase-3 activity and cell death. Cells were stained for
intracellular active caspase-3 and analyzed by ﬂow cytometry (the graph is representative of three independent experiments). e, f Puriﬁed CD4+
T cells were differentiated into Th1, Th2, and Treg subsets by activation with anti-CD3/CD28 for 2 or 3 days along with the appropriate cytokines (see
Materials and Methods). T-cell subsets were then cultured for an additional 2 or 3 days in IL-2 according to an established protocol11. e Baseline ECAR
was measured by extracellular ﬂux analysis (one-way ANOVA with Tukey’s correction; **p < 0.0001; mean ± S.D. of ﬁve replicates within the one
experiment shown. The graph is representative of two independent experiments). f Caspase activity was measured by DEVD rhodamine ﬂuorescence
(one-way ANOVA; **p < 0.0001; mean ± S.D. of three replicates within one experiment. The graph is representative of two independent experiments)
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The disparate levels of active caspase-3 in glycolytic vs.
non-glycolytic T cells suggested that they might differ in
their susceptibility to cell death following TCR restimu-
lation. Day 6 IL-2-cultured T cells cultured with and
without 2-DG were restimulated with anti-CD3. While 2-
DG induced more cell death prior to restimulation
(Fig. 5c), the 2-DG-treated cells were considerably more
resistant to RICD (Fig. 5d). RICD is primarily mediated by
Fas-ligand (FasL) signaling32. Therefore, we measured
FasL by western blot and found expression to be highest
in glycolytic IL-2-cultured T cells, and slightly less in non-
glycolytic IL-15-cultured and 2-DG-treated T cells
(Figs. 5e, f). However, the fact that the activities of
caspases-8 and -9 were not affected by 2-DG suggests that
FasL did not mediate caspase-3 activity in viable IL-2-
cultured T cells.
Active caspase-3 is sequestered in membrane lipid rafts in
effector T cells
Self-cleavage of caspases can occur when pro-caspases
are clustered in close proximity33, such as in lipid rafts
where caspase-8 is known to be active in effector
T cells34,35. To determine whether caspase-3 was localized
to membrane lipid rafts in effector T cells, lipid rafts were
puriﬁed from both glycolytic, IL-2-cultured T cells, and
non-glycolytic, IL-15-cultured T cells, and the resulting
fractions were analyzed for caspase-3 cleavage and activ-
ity. In IL-2-cultured glycolytic T cells, pro-caspase-3 was
present primarily in the non-raft fractions, and to a much
lesser extent in the raft fractions (Fig. 6a, raft fractions:
3–5; non-raft fractions: 10 and 11). However, caspase-3
was extensively cleaved only in the lipid raft fractions. In
the IL-15-cultured non-glycolytic T cells, pro-caspase-3
was also found predominantly in the non-raft fractions.
Although caspase-3 was also observed to be cleaved pri-
marily in the raft fractions of IL-15-cultured T cells, it was
to a lesser extent than in IL-2-cultured T cells (Fig. 6b).
Hence, the ratio of cleaved caspase-3 to pro-caspase-3 was
greater in the lipid rafts of IL-2-cultured glycolytic T cells
than in non-glycolytic IL-15-cultured T cells (Fig. 6c).
To conﬁrm that the cleaved caspase-3 observed in lipid
rafts was active, we performed a bVAD precipitation on
the lipid raft fractions 3–5 and the non-raft fraction 11.
Caspase-3 was found to be active at a much greater extent
in the raft fractions of IL-2-cultured glycolytic T cells,
compared with IL-15-cultured non-glycolytic T cells
(Figs. 6d, e).
Caspase-3 activity increases in effector T cells during
inﬂuenza infection
To determine whether active caspase-3 is observed in
activated T cells in vivo, mice were infected intranasally
with inﬂuenza virus strain A/Puerto Rico/8/1934 H1N1
(Flu) and lymphocytes from the lung-draining mediastinal
lymph node were analyzed after 6 days. Caspase-3 activity
was measured in naive (CD44low) and proliferating
effector (CD44high) CD4+ and CD8+ T cells (Fig. 7a). The
percentage of active caspase-3-positive cells, as well as the
median ﬂuorescence intensity (MFI) of active caspase-3
staining, were increased in the CD44high population of
both CD4+ and CD8+ T cells after Flu infection, com-
pared to the CD44low population (Fig. 7b).
Fig. 4 Glycolysis regulates caspase activity in effector T cells. Anti-CD3/CD28-activated T cells were cultured for 3 days in IL-2 with (a) 2-
deoxyglucose (2-DG, 0–5 mM). Baseline ECAR was measured (one-way ANOVA with Dunnett’s correction; **p < 0.001; mean ± S.E.M. of means from
three independent experiments). b, c Activated T cells were cultivated for 3 days in (b) IL-2 or (c) IL-15, in medium, 2-deoxyglucose (2-DG, 5 mM),
without glucose (No glucose), Rapamycin (300 nM), or DMSO control. Caspase activity was measured by DEVD rhodamine ﬂuorescence. Data indicate
a fold change compared to the control (one-way ANOVA with Dunnett’s correction; *p < 0.05; **p < 0.001; mean ± S.D.; n = 3 independent
experiments)
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Discussion
The present ﬁndings reveal that IL-2-mediated glyco-
lysis increases caspase-3 activity and the consequential
susceptibility of effector T cells to caspase-3-mediated cell
death. IL-15, by contrast, drives low levels of glycolysis
that favor low caspase-3 activity. The high amount of
oxidative metabolism in IL-15-cultured T cells also pro-
motes a further decrease in caspase-3 activity through its
glutathionylation. Our data support a model by which
glycolytic metabolism sets the stage for a high pro-
liferative rate of effector T cells that is coupled to
enhanced susceptibility to death cues through the activity
of downstream effector caspase-3.
Cleavage of caspase-3 can be induced by upstream
caspase-8 following Fas ligation, and by caspase-9 fol-
lowing cytochrome c release from the mitochondria. It is
also possible for cleavage of caspase-3 to occur by self-
activation when caspase-3 molecules are clustered in close
proximity33,36. We observed that the levels of both
caspase-8 and caspase-9 activity were similar between
glycolytic and non-glycolytic T cells, suggesting that they
are not likely to be the regulators of caspase-3 activity in
these different metabolic states. The ﬁndings are also
consistent with our previous observations that caspase-3
activity persists in effector T cells in which caspase-8 was
deleted37. It is possible that translocation to the cell
Fig. 5 Activity of caspase-3, but not caspase-8 or caspase-9, is regulated by the glycolytic state of effector T cells. Activated T cells were
cultured for 3 days in IL-2 with or without 5 mM 2-DG. a Active caspases were selectively precipitated using biotin-VAD (bVAD) and streptavidin
Sepharose beads, and immunoblotted for caspases-8, -9, -7, and -3 (the blot is representative of two independent experiments). b Densitometry of
active caspase-8, -9, -7, and -3 in (a; for caspase-8, -9, and -3: two-way ANOVA with Sidak’s correction; for caspase-7: unpaired t-test; NS not signiﬁcant;
*p < 0.05; mean ± S.D. of two replicates). c Cell death was determined by Live/Dead staining after centrifugation over Histopaque (unpaired t-test;
mean ± S.D.; **p < 0.01; n = 3 independent experiments). d Restimulation-induced cell death was promoted by 16 h anti-CD3 restimulation of IL-2-
cultured T cells cultured with or without 2-DG, and cell death determined by Live/Dead staining using ﬂow cytometry. Data indicate fold change
compared to the unstimulated medium control (two-way ANOVA with Sidak’s correction; NS not signiﬁcant; *p < 0.05; mean ± S.D. of two replicates;
n = 2 independent experiments). e Cell lysates of T cells grown in the indicated conditions were immunoblotted for FasL. Controls included FasL-
transfected 3T3 cells or mock-transfected 3T3 cells (the immunoblot is representative of two independent experiments). f Densitometry of FasL in (e;
one-way ANOVA; *p < 0.05; **p < 0.01; mean ± S.D. of two replicates)
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membrane, and particularly to lipid raft domains, allows
the clustering of full-length inactive caspase-3, and could
promote its proximity-induced autocleavage and activa-
tion36,38. Furthermore, while conﬁned to lipid rafts, active
caspase-3 may also be restricted in its access to substrates
that might induce cell death.
Effector T cells and memory T cells have very different
metabolic proﬁles. Similar to memory T cells derived
in vivo, memory-like T cells can be generated in vitro
through IL-15 signaling that promotes oxidative phos-
phorylation12,13. Consistent with those previous reports,
we observed that compared to IL-2, IL-15-cultured T cells
have elevated oxidative phosphorylation and mitochon-
drial ROS. Our ﬁndings further reveal that IL-15-cultured
T cells manifest glutathionylation of caspase-3, which is
known to inactivate caspase-3 at the critical cysteine in
the enzymatic pocket25. Given that glutathionylation of
caspase-3 was detected only of cleaved caspase-3 in IL-15-
cultured T cells, this suggests that caspase-3 is being
inactivated by glutathionylation after its cleavage. Along
with our previous report of the inactivation of caspase-3
by S-nitrosylation23, these data show that in T cells
caspase-3 can be inactivated by redox-dependent post-
translational modiﬁcations, which are inﬂuenced by the
metabolic state of the cell. Metabolically induced mod-
iﬁcations of apoptotic caspases may be an important
mechanism for memory T-cell formation.
The correlation between glycolysis and CD25 expres-
sion for in vitro-generated effector T cells is not surpris-
ing, given the known role of IL-2 in the induction of
Fig. 6 IL-2-mediated glycolysis promotes the localization and cleavage of caspase-3 in lipid rafts. Activated T cells were cultured for 3 days in
IL-2 or IL-15. a, b Cells were sonicated before fractionation in an ultracentrifuge over an Optiprep density gradient. Fractions of 1 mL each were
collected. A volume of 30 μL of each fraction was used to perform an immunoblot for capsase-3, GM-1 (lipid rafts), and paxillin (non-raft; the blot is
representative of two independent experiments). c Densitometry of the ratio of cleaved capsase-3 to pro-caspase-3 in raft and non-raft fractions (n =
2 independent experiments). d bVAD precipitation of active caspases was performed on the indicated raft and non-raft fractions, and precipitates
were immunoblotted for active caspase-3 (the blot is representative of two independent experiments). e Densitometry of active caspase-3 in raft and
non-raft fractions (n = 2 independent experiments)
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glycolysis in T cells. However, in vitro-differentiated Treg
cells, despite expressing high levels of CD25, are not
glycolytic, likely due to their derivation with TGFβ11,39.
We observed that these cells have low caspase activity,
indicating that caspase activity is a function of glycolysis
rather than CD25 expression.
Proliferating T cells are known to be susceptible to cell
death cues such as RICD40,41. Our data demonstrate
independent increases in both FasL and caspase-3 activity
in glycolytic IL-2-cultured T cells prior to TCR restimu-
lation. Consistent with our observations, a study recently
reported that human CD8+ T cells rapidly induced FasL
protein following TCR restimulation only when glycolytic,
rendering them more susceptible to RICD42. However, we
do not feel that the caspase-3 activity or the caspase-8
activity in proliferating glycolytic T cells is due to Fas/
FasL interactions for a few reasons. First, we observed no
increased levels of active upstream caspase-8 in IL-2-
cultured T cells despite more active caspase-3. Second, we
have previously shown that Fas-deﬁcient effector T cells
express as much active caspase-8 as wild-type T cells35.
Finally, reducing caspase-8 activity in effector T cells by
deleting its regulator, c-FLIP, had no effect on the levels of
active caspase-337. Hence, the collective ﬁndings would
indicate that the levels of active caspase-8 and caspase-3
in effector T cells are largely independent of one another
as well as independent of Fas/FasL interactions.
At present, the full spectrum of function of caspase-3
activity in viable effector T cells is unclear. Other reports
have noted a role for caspase-3 in T-cell anergy22, clea-
vage of p21 and cell cycling in B cells10, skeletal muscle
differentiation21, and maturation of erythrocytes, macro-
phages, and dendritic cells17. The localization of active
caspase-3 in membranes could provide access to sub-
strates important to these functions, while simultaneously
preventing the enzyme from cleaving pro-death sub-
strates. While it is possible that the glycolytic state of cells
may inﬂuence these other reported functions of caspase-3,
the current ﬁndings nonetheless link metabolism to
caspase-3 activity and thus provide a plausible regulatory
mechanism of immune cell homeostasis.
Materials and methods
Mice
C57BL/6NJ male mice (Jackson Laboratory, Bar Harbor,
ME) were housed in an Association for Assessment and
Fig. 7 Caspase-3 is active in vivo in proliferating T cells after inﬂuenza infection. Mice received inﬂuenza virus strain A/Puerto Rico/8/1934
H1N1 virus (FLU) or PBS control intranasally and lymph nodes were extracted 6 days after infection. Mediastinal lymph node cells (ﬂu-infected mice)
or non-mediastinal lymph node cells (PBS control mice) were stained and analyzed by ﬂow cytometry. a Representative contour plots of live CD4+
(left) or CD8+ (right) T cells from PBS control mice (top) or ﬂu-infected mice (bottom) for CD44 vs. active caspase-3. The two rectangular inserts
identify the CD44high (upper) and CD44low (lower) populations. All events to the right of the vertical line are positive for active caspase-3. Numbers
represent the percentage of CD44high or CD44low gated cells that are positive for active caspase-3 (% + ), and the median ﬂuorescent intensity of
active caspase-3 (MFI). b Graphs of the percent positive cells for active caspase-3 (top) and MFI (bottom; two-way ANOVA with Tukey’s correction;
mean ± S.D.; *p < 0.001, **p < 0.0001. NS not signiﬁcant. n = 5 mice per group)
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Accreditation of Laboratory Animal Care International-
approved facility at the University of Vermont Larner
College of Medicine. Mice were used at 2–6 months of
age, and protocols were approved by the Institutional
Animal Care and Use Committee.
Cell culture
T cells were puriﬁed from mouse lymph nodes (axillary,
inguinal, brachial, and cervical) and spleens by negative
selection as described previously23. Brieﬂy, lymph nodes
and spleens were homogenized through nylon mesh and
red blood cells were lysed with Gey’s solution. Combined
lymphocytes and splenocytes were incubated on ice for
30min with the following antibodies: anti-CD11b (M1/
70), anti-MHC class II (M5/114/15/2; a kind gift from M.
Rincón, Larner College of Medicine, University of
Vermont, Burlington, VT, USA), and anti-B220 (RA3-
6B2). Cells were then rocked over magnetic goat anti-rat
beads (Qiagen, Germantown, MD, USA) at a 10:1 bead:cell
ratio for 45min at 4 °C. Beads and bound cells were
removed with a magnet. Naive T cells were cultured in
RPMI-1640 (Corning, Manassas, VA, USA), supplemented
with 25mM HEPES, 100 U/mL penicillin–streptomycin
(ThermoFisher Scientiﬁc, Waltham, MA, USA), 5% bovine
calf serum (GE Healthcare HyClone, Logan, UT, USA), 2.5
mg/L glucose, 2 mM glutamine, 10 μg/mL folate, 1 mM
pyruvate, and 50 μM 2-mercaptoethanol (RPMI-C) and
stimulated on 10 μg/mL plate-bound anti-CD3 clone 145-
2C11 (Bio X Cell, West Lebanon, NH, USA) and soluble
anti-CD28 ascites clone 37–51 (1:1000), supplemented
with 50 U/mL IL-2 (Cetus, Emeryville, CA, USA) at 37 °C,
5% CO2. After 2 days, activated T cells were removed from
stimulation and cultured for an additional day in RPMI-C
and 50U/mL IL-2. Cells were then washed three times to
remove cytokines and cultured for 2–3 more days in
RPMI-C supplemented with either 50 U/mL IL-2 or 20 ng/
mL IL-15 (a kind gift from Amgen, Thousand Oaks, CA,
USA). For studies of the inhibition of glycolysis, T cells
were activated for 2 days in RPMI-C medium supple-
mented with 50 U/mL IL-2. Cells were then washed three
times and cultured in RPMI-C medium with 50 U/mL IL-2
and the indicated doses of 2-deoxy-D-glucose (Sigma-
Aldrich, St. Louis, MO, USA) or rapamycin (MP Biome-
dicals, Solon, OH, USA) for 3 days, replacing media,
cytokine, and inhibitor each day. IL-2-cultured T cells
cultured in 2-deoxy-D-glucose were centrifuged over
Histopaque-1077 (Sigma-Aldrich) to minimize the num-
ber of dead cells in the cultures prior to use in the assays.
Alternatively, cells were washed and cultured with glucose-
free RPMI-1640 (Corning) supplemented with 100 U/mL
penicillin–streptomycin, 5% bovine calf serum, 2mM
glutamine, 10 μg/mL folate, 1 mM pyruvate, and 50 μM 2-
mercaptoethanol (GF RPMI-C). Cells were then cultured
in GF RPMI-C supplemented with the indicated
decreasing concentrations of glucose for 3 days, replacing
the media each day.
Caspase activity assay
Caspase activity was measured using the Apo-ONE
Homogeneous Caspase-3/7 Assay Kit (Promega, Madison,
WI, USA) according to the manufacturer’s speciﬁcations.
Samples were analyzed using a Synergy HT Plate Reader
(BioTek, Winooski, VT, USA).
Cell lysis and immunoblot analysis
Cells were lysed for 20min on ice in Lysis Buffer A
(0.5% Nonidet P-40, 150mM NaCl, 20 mM Tris-HCl (pH
7.4), 10% glycerol, 2 mM sodium orthovanadate, and
Complete Protease Inhibitor (Roche Diagnostics,
Indianapolis, IN, USA)). Protein concentration was deter-
mined by Bradford Assay (Bio-Rad, Hercules, CA, USA).
Lysates were boiled for 5min in Laemmli loading buffer
supplemented with 2-mercaptoethanol (2-ME). Proteins
within the lysates were separated by SDS-PAGE on a 12%
acrylamide gel and transferred to a polyvinylidene
diﬂuoride (PVDF) membrane (Bio-Rad). Membranes were
blocked in 4% milk in Tris-buffered saline with 0.1%
Tween-20 (American Bioanalytic, Natick, MA, USA) at
room temperature for 1 h. The following antibodies were
used for protein detection: anti-caspase-3, 585 rabbit
polyclonal antibody (a kind gift from Dr. Yuri Lazebnik,
Cold Spring Harbor Laboratories, Cold Spring Harbor,
NY, USA), anti-caspase-8 (a kind gift from Dr. Andreas
Strasser, The Walter and Eliza Hall Institute of Medical
Research, Melbourne, Australia), anti-caspase-9, clone 5B4
(Stressgen Assay Designs, Ann Arbor, MI, USA), anti-
ﬂotillin (BD Biosciences), GM-1 HRP (Sigma-Aldrich),
anti-paxillin, clone 165 (BD Biosciences), anti-FasL
MAB5262 (R&D Systems, Minneapolis, MN, USA), anti-
β-actin (Sigma-Aldrich), anti-mouse IgG HRP, anti-rabbit
IgG HRP, and anti-rat IgG HRP (all from Jackson
Laboratory). Densitometry was performed using Image
Studio Lite v5 (LI-COR Biotechnology, Lincoln, NE, USA).
bVAD active caspase precipitation
Cells were washed once with PBS containing 1% bovine
serum albumin (PBS/1% BSA) and once with PBS, and then
incubated on ice for at least 20min with Lysis Buffer B
(0.2% Nonidet P-40,150mM NaCl, 20mM Tris-HCl (pH
7.4), 10% glycerol, 2 mM sodium orthovanadate, and
Complete Protease Inhibitor (Roche Diagnostics)) supple-
mented with 20 μM biotin-VAD-fmk (bVAD; MP Biome-
dicals). Protein was quantiﬁed by Bradford assay (Bio-Rad).
Overall, 400–600 μg of protein in 300 μL of Lysis Buffer B
(or 250 μg of protein for lipid raft fractions with no extra
buffer added) was pre-cleared by rocking over 40 μL of
Sepharose 4B beads (Sigma-Aldrich) for 2 h at 4 °C.
Supernatants were then rocked over streptavidin-Sepharose
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beads (ThermoFisher Scientiﬁc) overnight at 4 °C. Beads
were then washed three times with Lysis Buffer B without
protease inhibitor and boiled for 5min in Laemmli loading
buffer supplemented with 2-ME. For precipitations with
lipid raft and non-raft fractions, an equal amount of protein
was used from each fraction for the assay.
Glutathione immunoprecipitation
Cells were washed once with PBS/1% BSA and once
with PBS, and then incubated in Lysis Buffer B supple-
mented with 1 mM N-ethylmaleimide for at least 20 min
on ice. Protein was quantiﬁed by Bradford assay (Bio-
Rad). An amount of 300 μg of lysate was brought to 250
μL with lysis buffer. The reduced control was incubated
with 50mM dithiothreitol (+DTT) and rocked at 4 °C for
1 h. The reduced sample was then centrifuged through a
Micro Bio-Spin P-6 Gel Column (Bio-Rad). For the IgG
control, 5 μg of mouse IgG (Jackson Laboratory) was
added to the sample. For all other samples, 2 μg of anti-
glutathione antibody (Virogen, Watertown, MA, USA)
was added. All samples were rocked overnight at 4 °C.
Samples were added to 50 μL of washed Protein G Plus
Agarose (ThermoFisher Scientiﬁc) and rocked at 4 °C for
1 h. Beads were washed and boiled in Laemmli buffer
before being loaded onto a 15% acrylamide gel. Proteins
were separated by SDS-PAGE and transferred to a PVDF
membrane for immunoblot analysis.
Metabolic analyses
OCRs and ECARs were measured using the Seahorse
XFe 96 Analyzer (Agilent Technologies, Santa Clara, CA,
USA) according to the manufacturer’s speciﬁcations.
Analysis was performed using the Wave Software v2.2.0
or v2.3.0.2 (Agilent Technologies).
Flow cytometry
For surface staining, cells were washed in PBS and
stained with Live/Dead Fixable Blue Dead Cell Stain
(ThermoFisher Scientiﬁc) for 25min on ice. Cells were
washed and incubated for 25min on ice with anti-CD25-
BV421 (BioLegend, San Diego, CA, USA), anti-CD44-PE
(BioLegend), anti CD4-PE-TexasRed (ThermoFisher Sci-
entiﬁc), anti-CD8-PerCP-Cy5.5 (BioLegend), anti-TCRβ-
PE-Cy7 (BioLegend), and anti-CD45RB-FITC (BioLegend).
Cells were washed, ﬁxed in 1% (v/v) methanol-free for-
maldehyde, and analyzed on an LSRII (BD Biosciences).
For intracellular staining, after staining with Live/Dead
Fixable Blue Dead Cell Stain and surface antibodies as
described above, cells were washed and ﬁxed with 2%
formaldehyde (v/v) for 15min on ice. Fixed cells were
washed and permeabilized with PBS/1% BSA supple-
mented with 0.03% saponin for 10min on ice. Cells were
washed and incubated with anti-cleaved caspase-3 Alexa
647 (Cell Signaling) for 30min on ice. Cells were washed,
ﬁxed in 1% formaldehyde (v/v), and analyzed on an LSRII
(BD Biosciences).
All ﬂow cytometry data were analyzed with FlowJo
v10 software (FlowJo, Ashland, OR, USA).
Cellular and mitochondrial ROS measurement
Cellular ROS was measured using 2′,7′-dichlorodihy-
droﬂuorescein diacetate (DCFDA; ThermoFisher Scien-
tiﬁc). Overall, 5× 105 cells were incubated with 1 μM
DCFDA in PBS at 37 °C in the dark for 30 min. Cells were
washed with cold PBS/1% BSA and analyzed immediately
by ﬂow cytometry.
Mitochondrial ROS was quenched using MitoQ29. Cell
cultures were incubated with MitoQ or a DMSO control
for 4 h. Cells were then stained with DCFDA, as described
above, for ROS detection.
Mitochondrial ROS was measured using the MitoB
probe as previously described27. MitoB speciﬁcally targets
the mitochondria and is converted to MitoP in the pre-
sence of ROS. The ratio of MitoP/MitoB was measured
using liquid chromatography tandem mass spectrometry.
Complex I activity and mitochondrial extraction
Cells were washed with PBS/1% BSA and resuspended
in STE buffer (250 mM sucrose, 5 mM Tris, 1 mM
EGTA, pH 7.4 with HCl). Cells were homogenized and
centrifuged at 1000 g for 3 min at 4 °C. The supernatant
was then centrifuged at 10,000 g for 10 min at 4 °C. The
supernatant (cytosol) was saved and the pellet (mito-
chondria) was washed with STE buffer. The mitochon-
dria were then resuspended and assayed for Complex I
activity using the Complex I Enzyme Activity Micro-
plate Kit (MitoSciences, Eugene, OR, USA) according to
the manufacturer’s speciﬁcations. Samples were run in
parallel with mouse liver mitochondrial extracts as a
positive control. Complex I rates were calculated by
dividing Complex I activity by time. Complex I rates
were normalized to mouse liver mitochondrial complex
I rate.
Cell death
RICD was induced in day 6 or 7 effector T cells by
incubation on plate-bound anti-CD3 (10 μg/mL) for
16–18 h at 37 °C. Cells were removed and stained with
Live/Dead Fixable Blue Dead Cell Stain (ThermoFisher
Scientiﬁc), ﬁxed in 1% formaldehyde (v/v), and analyzed
by ﬂow cytometry.
As a positive control for cell death, day 6 effector T cells
were incubated with 400 ng/mL FLAG-tagged FasL (Enzo
Life Sciences, Farmingdale, NY, USA) and 2 μg/mL anti-
FLAG antibody M-2 (Sigma-Aldrich) for 1.5 h at 37 °C.
Cells were then stained with Live/Dead Fixable Blue Dead
Cell Stain (ThermoFisher Scientiﬁc) ﬁxed in 1% for-
maldehyde (v/v) and analyzed by ﬂow cytometry.
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CD4+ T-cell subset differentiation
Puriﬁed CD4+ T cells were activated in complete
medium on plate-bound anti-CD3/soluble anti-CD28 for
2 or 3 days in the presence of differentiating cytokines
(Th1: 4 ng/mL IL-12 (PeproTech, Rocky Hill, NJ, USA)
plus 10 μg/mL anti-IL-4 (BioLegend); Th2: 10 ng/mL IL-4
(PeproTech) plus 10 μg/mL anti-IFN-γ (BioLegend); Treg:
2 ng/mL TGF-β (PeproTech) plus 100 U/mL IL-2). After
differentiation, cultures were propagated for 2 or 3 days in
complete medium containing 50 U/mL IL-2 for Th1 and
Th2 cells, and 100 U/mL IL-2 for Treg.
Lipid raft puriﬁcation
Lipid rafts were separated as previously described35.
Brieﬂy, cells were lysed on ice for 25min in TNE buffer (5
mM iodoacetic acid (ThermoFisher Scientiﬁc), 150mM
NaCl, 10 mM Tris-HCl pH 7.4, 15 mM EDTA, Complete
Protease Inhibitor) supplemented with 100 mM Na2CO3
and 0.5% Triton X-100. Lysates were sonicated and added
to 60% Opti-Prep sucrose substitute (Sigma-Aldrich) to
make a ﬁnal concentration of 40% Opti-Prep. Lysates
were placed in an ultracentrifuge tube and layered over
with 30 and 5% solutions of Opti-Prep diluted with TNE
buffer. Samples were centrifuged for 18 h at 200,000g at
4 °C. Eleven 1mL fractions were taken sequentially from
each sample. An equal volume of each fraction was used
for immunoblot analysis.
Inﬂuenza infection of mice
Mouse-adapted inﬂuenza virus strain A/Puerto Rico/
8/1934 H1N1 (PR8) virus (Charles River Laboratories,
Wilmington, MA, USA) was used to infect mice. Mice
were brieﬂy anesthetized using 2.3% isoﬂurane in oxy-
gen and infected intranasally with a sublethal dose of
PR8 (0.2 LD50) in 0.05 ml of PBS. Control mice received
0.05 ml PBS without virus. Mice were monitored daily
until harvest on day 6, at which time the mediastinal
lymph node was harvested from the inﬂuenza-infected
mice, and axillary, brachial, and inguinal lymph nodes
were extracted from the PBS control mice. Lymphocytes
were collected and stained for analysis by ﬂow
cytometry.
Statistical analysis
Statistical analyses were performed using the graphing
software Prism v7 (GraphPad Software, La Jolla, CA,
USA). The statistical test used for each experiment is
indicated in the ﬁgure legends. The following statistical
tests were used: paired and unpaired t-test when com-
paring two conditions (e.g., IL-2 compared to IL-15), one-
way ANOVA with Tukey test, or Dunnett test (when
comparing to one control) for correction for multiple
comparisons when comparing multiple conditions for a
single variable (e.g., dose titration of 2-DG), two-way
ANOVA with Sidak test, or Tukey test for correction for
multiple comparisons when comparing multiple variables
across multiple conditions (e.g., IL-2 with and without
anti-CD3 compared to IL-15 with and without anti-CD3).
All data met the assumptions of the statistical tests used
and variation between the compared groups was similar.
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